⌘K

Login Start Free

Home/Filings/4/0000899243-20-012600

4//SEC Filing

Maimon Yossi 4

Accession 0000899243-20-012600

CIK 0001797336other

View on SEC.gov Company Profile

Filed

May 10, 8:00 PM ET

Accepted

May 11, 5:39 PM ET

Size

4.9 KB

Accession

0000899243-20-012600

Insider Transaction Report

Form 4

Period: 2020-05-07

Ayala Pharmaceuticals, Inc.AYLA

CFO

Transactions

Award
Common Stock
2020-05-07+11,352→ 11,352 total

Footnotes (1)

[F1]Represents an award of restricted stock, which will vest as to 25% of the shares on May 7, 2021 and as to the remaining shares in 12 quarterly installments thereafter.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Ayala Pharmaceuticals, Inc.

CIK 0001797336

Entity typeother

Related Parties

1

filerCIK 0001385115

Filing Metadata

Form type: 4
Filed: May 10, 8:00 PM ET
Accepted: May 11, 5:39 PM ET
Size: 4.9 KB

View on SEC.gov